Indefinite Delivery Contract 36C26322D0029

Award Date 1/1/22
Last Date to Order 12/31/26
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a single-award indefinite delivery contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide a range of general radiopharmaceutical products and services. The $6.9 million IDV, which has a base period of performance from August 1, 2023 through July 31, 2028, allows for the ongoing supply of radiopharmaceuticals, radioactive isotopes, diagnostic imaging agents, and specialty...
The Department of Veterans Affairs (VA) awarded an indefinite delivery contract (IDC) to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract, valued at $350,000, is for the manufacturing and delivery of radiopharmaceuticals to VA medical centers. This single-award IDC has a base period of performance from November 12, 2024 to November 11, 2025. Under this contract, Cardinal Health 414 will provide a range of radiopharmaceuticals,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a multiple-award indefinite delivery contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals and related services to VA medical facilities. The contract, valued at up to $39.8 million, allows for the ongoing supply of radioisotopes, diagnostic imaging agents, and specialty radiopharmaceutical treatments to support nuclear medicine, oncology, and imaging programs...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a single-award indefinite delivery contract (IDC) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract has a ceiling value of $2,250,000 and a term from February 1, 2021 to January 31, 2026, allowing for the ongoing supply of a wide range of radioisotope-based products to support nuclear medicine, oncology, and diagnostic imaging...
The key points are: This is a federal Indefinite Delivery Contract (IDC) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $4,514,344.70 and a period of performance through June 30, 2029. The contract is for the delivery of nuclear medicine radiopharmaceuticals such as technetium-99m, iodine-123, iodine-131, and others to support nuclear...
This federal contract IDV award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $833,238.27 and a period of performance through September 30, 2027. Cardinal Health 414 is an experienced supplier of critical medical isotopes, radiopharmaceuticals, and specialized pharmaceutical products to federal healthcare agencies, including the VA, Department...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 6 (VISN 6) awarded an Indefinite Delivery Contract (IDC) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. This single-award IDC, valued at up to $992,001.12, is for the supply of standard radiopharmaceutical products to support nuclear medicine, oncology, and diagnostic imaging services at VA medical facilities nationwide. The contract has a period of performance...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a single-award, indefinite delivery contract to Cardinal Health, Inc. for radiopharmaceutical products. The potential value of the contract is $773,677.24 with a period of performance from February 22, 2022 to February 21, 2023. Under this contract, Cardinal Health will provide radiopharmaceuticals to support medical imaging procedures for patients within the VA healthcare system....
The Department of Veterans Affairs Veterans Health Administration awarded a single award Indefinite Delivery Contract to Cardinal Health 414, LLC for radiopharmaceuticals. Over the five year period of performance from April 2020 to March 2025, the contract has a potential value of $5,000,000. Delivery orders have been issued on an annual basis for quantities of radiopharmaceuticals to support diagnostic imaging services provided by VHA medical centers in Veterans Integrated Service Network 21....
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the multi-station purchase of radiopharmaceuticals to support nuclear medicine, oncology, and diagnostic imaging services at various VA medical facilities. The total ceiling value of the IDC is $6,743,986.65, with individual delivery orders ranging from...
  • 36C26322D0029
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

This indefinite delivery contract, awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA), is for the provision of radiopharmaceuticals to support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers. The prime contractor is Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc.

The contract, valued at up to $3,004,505.30, has a period of performance from January 1, 2022 to December 31, 2026. It includes multiple delivery orders for the supply of radiopharmaceuticals such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has no set-aside designation, reflecting Cardinal Health 414's status as a large, established provider of specialized medical products to federal healthcare agencies. The delivery orders have firm fixed-price structures and cover various VA medical facilities in locations such as Omaha, Nebraska, and Dublin, Ohio.

Generated 4/4/25, 9:49 AM